Plasma exchange in highly sensitized patients as induction therapy after renal transplantation.
Reisaeter
A V
AV
Medical Department B, National Hospital, Oslo, Norway.
Fauchald
P
P
Leivestad
T
T
Holdaas
H
H
Hartmann
A
A
Pfeffer
P
P
Sødal
G
G
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000628:therapy; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007518:Isoantibodies / Q000097:blood*; D016030:Kidney Transplantation / Q000276:immunology*; D016853:Muromonab-CD3 / Q000627:therapeutic use; D010951:Plasma Exchange; D011239:Prednisolone / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D007518:Isoantibodies; D016853:Muromonab-CD3; D016572:Cyclosporine; D003520:Cyclophosphamide; D011239:Prednisolone